Top Stories
A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

A smartphone on a surface showing Chipotle ad on screen

If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today

They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many

Latest News

Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity

GlobeNewswire Inc.

In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving clear / almost clear skinFollowing positive Phase 2 LI

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

GlobeNewswire Inc.

The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg once-daily in dermatomyositisBrepocitinib 30 mg was superior to placebo on the primary an

Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis

GlobeNewswire Inc.

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI 100 (41.0%, 39.5%)Quality‑of‑life improvements and itch relief emerged ahead of PASI 90 skin clearance, an

Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting

GlobeNewswire Inc.

Investigational ZORYVE® (roflumilast) cream 0.05% was well tolerated with safety findings consistent with prior pediatric experience in the INTEGUMENT programZORYVE cream improved signs and symptoms of mild to moderate atopic dermatitis in infants ag

Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire Inc.

Featured presentation highlights positive BroADen Phase 1b atopic dermatitis trial results supporting KT-621’s compelling oral profile Parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-20

Searchless.ai Launches as the First Publication Dedicated to Covering the End of Traditional Search

Newsfile

New daily intelligence publication tracks the shift from Google to AI-powered discovery as 56% of searches now end without a clickRome, Italy--(Newsfile Corp. - March 28, 2026) - Searchless.ai has launched as a new publication focused on exclusively

Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency

GlobeNewswire Inc.

Rocket Lab Electron Launch For European Space Agency Rocket Lab Electron Launch For European Space Agency MAHIA, New Zealand, March 28, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or the “Company”), a global leader in

McLaren Resources Completes Financing

Newsfile

Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - McLaren Resources Inc. (CSE: MCL) (FSE: 3ML) ("McLaren" / the "Company") announces final closing of a non-brokered private placement financing. McLaren has raised gross total proceeds of $662,500.

CopAur Minerals to Provide a Kinsley Mountain Update on the Emerging Growth Conference on April 2nd, 3:40 - 3:50 pm Eastern Time

Newsfile

Vancouver, British Columbia--(Newsfile Corp. - March 27, 2026) - Andrew Neale, CEO of CopAur Minerals Inc. (TSXV: CPAU) (the "Company") invites individual and institutional investors as well as advisors and analysts, to attend the Company's real-time

Spin.AI Named Winner of the Coveted Global InfoSec Awards During RSAC Conference 2026

Newsfile

San Francisco, California--(Newsfile Corp. - March 27, 2026) - Spin.AI is honored to announce that it has been recognized as a winner of five awards from Cyber Defense Magazine (CDM), the industry's leading electronic information security magazine, a